Drug Report History #182060
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated | 2023-01-20 | 2023-01-20 |
| Drug Identification Number | 02439212 | 02439212 |
| Brand name | IBAVYR | IBAVYR |
| Common or Proper name | IBAVYR | IBAVYR |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Ingredients | RIBAVIRIN | RIBAVIRIN |
| Strength(s) | 200MG | 200MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100 | 100 |
| Additional packaging sizes | ||
| ATC code | J05AP | J05AP |
| ATC description | ||
| Reason for discontinuation | Manufacturing issues | Manufacturing issues |
| Anticipated discontinuation date (Changed) | Updated to: | Was: 2022-12-09 |
| Actual discontinuation date (Changed) | Updated to: 2022-12-09 | Was: |
| Remaining supply date | 2023-03-15 | 2023-03-15 |
| Discontinuation status (Changed) | Updated to: Discontinued | Was: To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |